Is This Biotech Stock Immune to Volatility?
Biotech stock DCPH is down 80% since the pandemic, but it’s UP so far in 2022. Will the stock land on Chad’s Bank It list today?
Posted by Chad Shoop | Jun 16, 2022 | Investing, Quick Takes, Trading Strategies, True Options Masters
Biotech stock DCPH is down 80% since the pandemic, but it’s UP so far in 2022. Will the stock land on Chad’s Bank It list today?
The Banyan Edge is a daily look at what our top investment experts are buying, selling, and analyzing. Enter your email and start investing with an edge today.
Editor of One Trade and Precision Profits
Research Analyst
Investment Strategist
Editor of Strategic Fortunes and three elite services
Director of Investment Research
Editor of Alpha Investor
Director of VIP Services
“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”
- David G. (Member since 2018)
“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”
- Larry K.
"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"
- Keith S.